LAB.US Standard Biotools Inc

Healthcare Life Sciences Tools & Services USA Stocks
0.7074 USD
Close of Nov 15, 2026
0.5900 1.72
Market cap
USD 279M
P/E
-
P/B
0.50x
ROE
-14.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LAB.US undervalued?

Graham number

The Graham number of Standard Biotools Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Standard Biotools Inc fundamental analysis

No fundamental analysis for Standard Biotools Inc yet.

Standard Biotools Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Standard Biotools Inc

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides So…

Full company profile